Canada· CA-DIN-02533065
MAR-CYPROHEPTADINE
A cyproheptadine product containing cyproheptadine hydrochloride, registered in Canada by MARCAN PHARMACEUTICALS INC. The same ATC class is registered in 10 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Cyproheptadine is registered in 10 of 19 countries.
Countries holding a registration under ATC R06AX02 (cyproheptadine), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 6 of them publish a price we can compare per daily dose
Cyproheptadine · ATC R06AX02
10 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Finlandprice
- Germany
- Japan
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- CYPROHEPTADINE HYDROCHLORIDE
- Manufacturer
- MARCAN PHARMACEUTICALS INC
- Country
- Canada (CA)
- ATC code
- R06AX02
- ATC class
- Cyproheptadine
- Defined daily dose
- 12 mg, O
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
327 interactions on record for cyproheptadine.
Graded by severity as the source publishes them — 9 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Cyproheptadine · interactions on record
327 records
- 9 severe
- 316 moderate
- 2 minor
Most severe, free to view
- Potassium chlorideA12BA01severe
- Potassium citrateA12BA02severe
- Potassium chlorideB05XA01severe
- Sodium oxybateN01AX11severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Cyproheptadine in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesCyproheptadine HydrochlorideREMEDYREPACK INC.
- CzechiaPERITOL
- NorwayCyproheptadine HClCypress Pharmaceutical
- United KingdomCyproheptadine 4mg tabletsSpecial Order
- FrancePERIACTINE 4 mg, compriméTEOFARMA
- PolandPeritolEgis Pharmaceuticals PLC
- SpainPERIACTIN 4 MG COMPRIMIDOSAlfasigma Espana S.L.
- GermanyPeritolAbanta Pharma Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 9 EEA countries. Names it is sold under:
- Czechia · Peritol
- Germany · Peritol
- Spain · Periactin
- France · Periactine
- Hungary · Peritol
- Italy · Periactin
- Poland · Peritol
- Portugal · Viternum
- Slovakia · Peritol
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bea202fb-1dd4-417b-92d4-69fe6b066fc4 GET /v1/drugs/bea202fb-1dd4-417b-92d4-69fe6b066fc4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02533065",
"form": "TABLET",
"class": "Human",
"routes": [
"ORAL"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "R06AX02",
"schedule": [
"OTC"
],
"drug_code": "102209",
"strengths": [
"4 MG"
],
"ahfs_class": null,
"substances": [
"CYPROHEPTADINE HYDROCHLORIDE"
],
"product_categorization": "LS - CYPROHEPTADINE"
}See everything about cyproheptadine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.